Employment and Support Allowance:Written question - 130800

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

To ask the Secretary of State for Work and Pensions, how many employment and support allowance claimants with (a) cystic fibrosis, (b) rheumatoid arthritis, (c) motor neurone disease, (d) multiple sclerosis and (e) Parkinson's disease have been (i) placed in the support group, (ii) placed in the work-related activity group and (iii) found fit for work at Work Capability Assessments in each year since 2008.

Number of Employment and Support Allowance (ESA) claimants with at least one work capability assessment outcome, with a main disabling condition of Cystic Fibrosis, Motor Neurone Disease, Multiple Sclerosis, Parkinson’s Disease or Rheumatoid Arthritis, by assessment type, assessment outcome and year 20082 to 20174, Great Britain

‘000s

Condition

Year of completed assessment

Assessment type - Outcome

08

09

10

11

12

13

14

15

16

17

Total

Cystic Fibrosis

Initial - Support Group

-

0.1

0.1

0.1

0.2

0.1

0.2

0.2

0.1

0.1

1.0

Initial - WRAG

-

-

0.1

-

-

-

-

-

-

-

0.1

Initial - Fit for Work

-

-

0.1

-

-

-

-

-

-

-

0.1

Repeat - Support Group

-

-

-

0.1

0.1

0.1

0.1

-

0.2

0.1

0.6

Repeat - WRAG

-

-

-

-

-

-

-

-

-

-

0.1

Repeat - Fit For Work

-

-

-

-

-

-

-

-

-

-

-

IBR - Support Group

.

.

.

0.1

0.2

0.3

0.1

-

-

-

0.6

IBR - WRAG

.

.

.

-

-

-

-

-

-

-

0.1

IBR - Fit for Work

.

.

.

-

-

-

-

-

-

-

-

Motor Neurone Disease

Initial - Support Group

-

0.1

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.1

1.5

Initial - WRAG

-

-

-

-

-

-

-

-

-

-

0.1

Initial - Fit for Work

-

-

-

-

-

-

-

-

-

-

-

Repeat - Support Group

-

-

-

-

0.1

0.1

-

-

0.1

-

0.3

Repeat - WRAG

-

-

-

-

-

-

-

-

-

-

-

Repeat - Fit For Work

-

-

-

-

-

-

-

-

-

-

-

IBR - Support Group

.

.

.

-

0.1

0.1

-

-

-

-

0.2

IBR - WRAG

.

.

.

-

-

-

-

-

-

-

-

IBR - Fit for Work

.

.

.

-

-

-

-

-

-

-

-

Multiple Sclerosis

Initial - Support Group

-

0.5

0.7

0.9

1.5

1.3

1.8

1.5

1.1

0.7

9.7

Initial - WRAG

-

0.7

0.9

0.5

0.3

0.1

0.1

0.1

0.1

-

2.8

Initial - Fit for Work

-

0.4

0.4

0.3

0.3

0.2

0.1

0.2

0.3

0.1

2.2

Repeat - Support Group

-

-

0.2

0.8

2

2

1.8

0.4

3.7

1.1

9.7

Repeat - WRAG

-

-

0.4

0.6

0.7

0.3

0.1

-

0.1

-

1.7

Repeat - Fit For Work

-

-

-

0.1

0.1

0.1

-

-

0.1

0.1

0.5

IBR - Support Group

.

.

.

1.4

4.2

7

2.3

0.7

0.5

0.1

16.2

IBR - WRAG

.

.

.

0.5

1.1

0.9

0.1

-

-

-

2.6

IBR - Fit for Work

.

.

.

0.1

0.1

0.1

-

-

-

-

0.3

Parkinsons Disease

Initial - Support Group

-

0.1

0.1

0.2

0.3

0.3

0.4

0.4

0.2

0.2

2.1

Initial - WRAG

-

0.2

0.3

0.1

0.1

-

-

-

-

-

0.8

Initial - Fit for Work

-

0.2

0.1

0.1

0.1

-

-

0.1

0.1

0.1

0.8

Repeat - Support Group

-

-

-

0.1

0.3

0.3

0.2

0.1

0.4

0.1

1.3

Repeat - WRAG

-

-

0.1

0.2

0.2

0.1

-

-

-

-

0.4

Repeat - Fit For Work

-

-

-

-

-

-

-

-

-

-

0.1

IBR - Support Group

.

.

.

0.1

0.3

0.6

0.2

-

-

-

1.3

IBR - WRAG

.

.

.

-

0.1

0.1

-

-

-

-

0.3

IBR - Fit for Work

.

.

.

-

-

-

-

-

-

-

-

Rheumatoid Arthritis

Initial - Support Group

-

0.2

0.2

0.3

0.6

0.6

1.0

0.9

0.5

0.3

4.5

Initial - WRAG

-

0.7

0.9

0.6

0.6

0.3

0.2

0.2

0.2

0.1

3.7

Initial - Fit for Work

-

0.8

0.9

0.6

0.7

0.5

0.3

0.6

0.6

0.3

5.2

Repeat - Support Group

-

-

0.1

0.3

0.8

1.4

1.5

0.4

1.9

0.8

5.9

Repeat - WRAG

-

-

0.4

0.8

1.2

0.8

0.4

0.1

0.2

0.1

3

Repeat - Fit For Work

-

-

0.1

0.3

0.3

0.2

0.2

0.1

0.4

0.2

1.7

IBR - Support Group

.

.

.

0.5

1.5

2.6

1.1

0.5

0.3

0.1

6.6

IBR - WRAG

.

.

.

0.8

2.2

1.7

0.3

0.1

-

-

5

IBR - Fit for Work

.

.

.

0.2

0.5

0.3

0.1

-

-

-

1.2

Source: Application data is derived from administrative data held by the DWP and assessment data provided by the Healthcare Provider.

Notes:

The figures are rounded to the nearest 100. “–” denotes zero or fewer than 50. ‘.’ denotes not applicable.

The information for 2008 covers the period from October 2008 only; this is the first month for which this information is recorded.

National roll-out of Incapacity Benefit Reassessments (IBR) began in March 2011. As a result, the 2011 figures for IB reassessment cover the period from March to December only.

The information for 2017 is provided up to June 2017 only; this is the latest data available at time of request.

An individual may have made more than one ESA claim or had more than one assessment in any given year. These individuals will only be counted once in each of the figures provided.

The primary medical condition recorded on the claim form does not itself confer entitlement to ESA. So, for example, a decision on entitlement for a customer claiming ESA on the basis of Cystic Fibrosis would be based on their ability to carry out the range of activities assessed by the work capability assessment.

Initial refers to customers who are having their first assessment after making a claim for ESA, whereas Repeat refers to any assessments done following the initial assessment.

IBR refers to customers who are having their first ESA assessment after having migrated over from Incapacity Benefit.